AT441666T

Antibodies against fibroblast growth factor 23

Abstract

A objective of the present invention provides anti-fibroblast Growth factor-23 antibody. Namely, wherein the control phosphate or metabolism the group comprising metabolism an antibody, and (a), (b), (c) antibody, wherein the antibody comprising the polypeptide of amino acid sequence by use of one of shown in SEQ ID NO: 1 or comprising one or more from the amino acid sequence of SEQ ID NO: 1 as a deletion, wherein the or incremental an amino acid sequence of amino acid and at most obtained, and a fibre growth factor 23 active polypeptide immune animals to obtain. the (a) a recognition to SEQ ID NO: 1 in the amino acid sequence in a 180th to 194th or 237th amino acid sequence of said 251st. the (b) a collection number of FERM BP-7838 FERM, BP-7839, FERM, BP-7840 antibody or BP-8268 FERM hybridoma producing. the (c) one of the collection number of FERM BP-7838 FERM, BP-7839, FERM, BP-7840 one of competition antibody or BP-8268 FERM hybridoma producing.

Term

No projected expiry on record.

  1. Priority
  2. Filed
  3. Granted
  4. Today

21 members in 12 offices

This recordMember, by publication datePriority claim2 more offices are in the list below

Priority claims3

Priority claims
DocumentOfficeKindDate
2001401689JapanA
2002262020JapanA
0300017JapanW

Members21

Family members, oldest first
DocumentOfficeKind
CA2471656A1CanadaA1
WO03057733A1World Intellectual Property Organization (WIPO)A1
AU2003202472A1AustraliaA1
KR20040073518ARepublic of KoreaA
EP1466925A1European Patent Office (EPO)A1
US2005048058A1United States of AmericaA1
JPWO2003057733A1JapanA1
CN1639193AChinaA
EP1466925A4European Patent Office (EPO)A4
HK1078093AHong Kong, ChinaA
CN100519584CChinaC
EP1466925B1European Patent Office (EPO)B1
AT441666TThis recordAustriaT
ATE441666T1AustriaT1
DE60329070D1GermanyD1
AU2003202472B2AustraliaB2
ES2331414T3SpainT3
JP4527982B2JapanB2
KR101016476B1Republic of KoreaB1
US7923012B2United States of AmericaB2
CA2471656CCanadaC